Cathepsin D expression by cancer and stromal cells in breast cancer: An immunohistochemical study of 1348 eases

Breast Cancer Research and Treatment

Volumn 55, Issue 2, 1999, Pages 137-147

  Têtu, Bernard ^a,b   Brisson, Jacques ^a   Lapointe, Hélène ^a   Wang, Chang Shu ^a   Bernard, Pascale ^a   Blanchette, Caty ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Breast cancer; Cathepsin D; Immunohistochemistry; Protease

Indexed keywords

CATHEPSIN D; GELATINASE A; PROTEINASE; STROMELYSIN; UROKINASE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CELL; CANCER RECURRENCE; CANCER SURVIVAL; CELL STIMULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; STROMA CELL;

ADENOCARCINOMA; ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CATHEPSIN D; CELL COUNT; DISEASE-FREE SURVIVAL; ENDOPEPTIDASES; ENZYME INDUCTION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOENZYME TECHNIQUES; LIFE TABLES; LYMPHATIC METASTASIS; MACROPHAGES; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; QUEBEC; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; RISK FACTORS; STROMAL CELLS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR STEM CELLS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032788235     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Ferrandina G, Scambia G, Bardelli F, Benedetti Panici P, Mancuso S, Messori A: Relationship between cathepsin-D content and disease-free survival in node-negative breast cancer patients: a meta-analysis. Br J Cancer 76: 661-666, 1997
2. Isola J, Weitz S, Visakorpi T, Holli K, Shea R, Khabbaz N, Kallioniemi OP: Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer. J Clin Oncol 11: 36-43, 1993
3. Lösch A, Tempfer C, Kohlberger P, Joura EA, Denk M, Zajic B, Breitenecker G, Kainz C: Prognostic value of cathepsin D expression and association with histomorphological subtypes in breast cancer. Br J Cancer 78: 205-209, 1998
4. Domagala W, Striker G, Szadowska A, Dukowicz A, Weber K, Osborn M: Cathepsin D in invasive ductal NOS breast carcinoma as defined by immunohistochemistry. No correlation with survival at 5 years. Am J Pathol 141: 1003-1012, 1992
5. Kandalaft PL, Chang KL, Ahn CW, Traweek ST, Mehta P, Battifora H: Prognostic significance of immunohistochemical analysis of cathepsin D in low-stage breast cancer. Cancer 71: 2756-2763, 1993
6. Henry JA, McCarthy AL, Angus B, Westley BR, May FEB, Nicholson S, Cairns J, Harris AL, Home CHW: Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer: an immunohistochemical study. Cancer 65: 265-271, 1990
7. Têtu B, Brisson J, Côté C, Brisson S, Potvin D, Roberge N: Prognostic significance of cathepsin D expression in node-positive breast carcinoma: an immunohistochemical study. Int J Cancer 55: 429-435, 1993
8. Joensuu H, Toikkanen S, Isola J: Stromal cell cathepsin D expression and long-term survival in breast cancer. Br J Cancer 71: 156-159, 1995
9. Nadji M, Fresno M, Nassiri M, Conner G, Herrero A, Morales AR: Cathepsin D in host stromal cells, but not in tumor cells, is associated with aggressive behavior in node-negative breast cancer. Hum Pathol 27: 890-895, 1996
10. O'Donoghue AEMA, Poller DN, Bell JA, Galea MH, Elston CW, Blamey RW, Ellis IO: Cathepsin D in primary breast carcinoma: adverse prognosis is associated with expression of cathepsin D in stromal cells. Breast Cancer Res Treat 33: 137-145, 1995
11. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29: 577-580, 1981
12. Dressler LG, Bartow SA: DNA flow cytometry in solid tumors: practical aspects and clinical applications. Sem Diagn Pathol 6: 55-82, 1989
13. Erdos T, Best-Belpomme M, Bessada R: A rapid assay for binding estradiol to uterine receptor(s). Anal Biochem 37: 244-252, 1970
14. Wolf C, Rouyer N, Lutz Y, Adida C, Loriot M, Bellocq JP, Chambon P, Basset P: Stromelysin-3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc Natl Acad Sci USA 90: 1843-1847, 1993
15. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Amer Statist Assoc 53: 453-481, 1958
16. Armitage P: Statistical Methods in Medical Research. John Wiley & Sons, New York, 1991
17. Cox DR: Regression models and lifetables (with discussion). JR Statist Soc 34: 187-220, 1972
18. Ravdin PM, Tandon AK, Allred DC, Clark GM, Fuqua SA, Hilsenbeck SH, Chamness GC, Osborne CK: Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancer. J Clin Oncol 12: 467-474, 1994
19. Winstanley JH, Leinster SJ, Cooke TG, Westley BR, Platt HA, Rudland PS: Prognostic significance of cathepsin-D in patients with breast cancer. Br J Cancer 67: 767-772, 1993
20. Johnson MD, Tori JA, Lippman ME, Dickson RB: The role of cathepsin D in the invasiveness of human breast cancer cells. Cancer Res 53: 873-877, 1993
21. Tandon AK, Clark GM, Chamness GC, Chirgwin JM, McGuire WL: Cathepsin D and prognosis in breast cancer. N Engl J Med 322: 297-302, 1990
22. Duffy MJ, Brouillet JP, Reilly D, McDermott E, O'Higgins N, Fennelly JJ, Maudelonde T, Rochefort H: Cathepsin D concentration in breast cancer cytosols: correlation with biochemical, histological, and clinical findings. Clin Chem 37: 101-104, 1991
23. Romain S, Muracciole X, Varette I, Bressac C, Brandone H, Martin PM: La cathepsine D: un facteur pronostique indépendant dans le cancer du sein. Bull Cancer Paris 77: 439-447, 1990
24. Spyratos F, Maudelonde T, Brouillet JP, Brunet M, Defrenne A, Andrieu C, Hacene K, Desplaces A, Rouesse J, Rochefort H: Cathepsin D: an independent prognostic factor for metastatsis of breast cancer. Lancet 2: 1115-1118, 1989
25. Razumovic JJ, Stojkovic RR, Petrovecki M, Gamulin S: Correlation of two methods for determination of cathepsin D in breast carcinoma (immunohistochemistry and ELISA in cytosol). Breast Cancer Res Treat 43: 117-122, 1997
26. Roger P, Montcourrier P, Maudelonde T, Brouillet JP, Pages A, Laffargue F, Rochefort H: Cathepsin D immunostaining in paraffin-embedded breast cancer cells and macrophages: correlation with cytosolic assay. Hum Pathol 25: 863-871, 1994
27. Charpin C, Devictor B, Bonnier P, Andrae L, Lavaut MN, Allasia C, Piana L: Cathepsin D immunocytochemical assays in breast carcinomas: image analysis and correlation to prognostic factors. J Pathol 170: 463-470, 1993
28. Ravdin PM, Chamness GC: The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular markers - a review. Gene 159: 19-27, 1995
29. Têtu B, Brisson J: Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer. The influence of the pattern of immunostaining and adjuvant therapy. Cancer 73: 2359-2365, 1994
30. Pupa SM, Bufalino R, Invernizzi AM, Andreola S, Rilke F, Lombardi L, Colnaghi MI, Menard S: Macrophage infiltrate and prognosis in c-erbB-2-overexpressing breast carcinomas. J Clin Oncol 14: 85-94, 1996
31. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL: Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56: 4625-4629, 1996
32. Noël AC, Polette M, Lewalle JM, Munaut C, Emonard HP, Birembaut P, Foidart JM: Coordinate enhancement of gelatinase A mRNA and activity levels in human fibroblasts in response to breast-adenocarcinoma cells. Int J Cancer 56: 331-336, 1994
33. Ito A, Nakajima S, Sasaguri Y, Nagase H, Mori Y: Coculture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteinases 1, 2 and 3 in fibroblasts. Br J Cancer 71: 1039-1045, 1995
34. Biswas C, Zhang Y, DeCastro R, Guo H, Nakamura T, Kataoka H, Nabeshima K: The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 55: 434-439, 1995
35. Gasparini G, Harris L: Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol 13: 765-782, 1995
36. Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991
37. Hildenbrand R, Dilger I, Horlin A, Stutte HJ: Urokinase plasminogen activator induces angiogenesis and tumor vessel invasion in breast cancer. Pathol Res Pract 191: 403-409, 1995